Enamine's library of 5400 TPD-related linkers, as well as 13,000 additional linker molecules, is now integrated into Cresset's Spark library search tool Cambridge, UK-based Cresset announced on Aug. 5, 2024, that it plans to enhance its global collaboration with Enamine in the area of targeted
Synovial sarcoma is a relatively uncommon type of cancer that affects approximately 1000 adults in the United States annually, with a higher incidence among men in their 30s or younger On August 2, 2024, the FDA approved Tecelra (afamitresgene autoleucel), a groundbreaking gene therapy developed by Adaptimmune. This therapy is
Freudenberg Medical has added custom single-use assemblies to the silicone extrusion and molding services it already provides Freudenberg Medical revealed on August 1, 2024, that it has added custom single-use assemblies to its line of biopharma products. These will be combined with the company's silicone extrusion and molding
BeiGene has committed $800 million in a new biologics manufacturing plant in Hopewell, New Jersey, which also includes clinical research and development capabilities BeiGene, an oncology business, announced on July 23, 2024 that it has established a new biologics production facility at the Princeton West Innovation Campus in Hopewell, New
Through the acquisition, Olink will become a part of Thermo Fisher's Life Sciences Solutions business Thermo Fisher Scientific has successfully acquired Olink Holding, a provider of advanced proteomics solutions based in Sweden. The transaction, valued at around $3.1 billion, was finalized on July 10, 2024, as stated
The corporation refers to its hunt for novel ways as crowdsourcing, and it will pay at least one cash prize The "New Drug Delivery Systems and Treatments for Improved Adherence and Better Management of Epilepsy" challenge was announced on June 28, 2024 by Angelini Pharma, a division of
Syngene has introduced a novel protein synthesis platform that provides faster output while lowering risk Syngene International, a contract research, development, and manufacturing organization (CRDMO), has introduced a novel protein production platform designed for quick production. The platform is built on cell line and transposon technologies licensed by Syngene from
AGC Biologics has finished an expansion at its site in Copenhagen, Denmark. This makes its bioreactors twice as big for mammals cell growth AGC Biologics said that a new production building would be finished at its campus in Copenhagen, Denmark, in early June 2024. The increase doubles the site'
Valuable insights into the integration of digital chemistry, robotics, and AI in the drug discovery process Researchers in the UK have successfully addressed optimization problems that are typically handled by quantum computers using the pulsating Belousov-Zhabotinsky (BZ) reaction. Lee Cronin's research team at the University of Glasgow utilizes
CGT Catapult and CATTI have collaborated to develop training standards for advanced therapy manufacturing Cell and Gene Therapy Catapult (CGT Catapult) and the Canadian Advanced Therapies Training Institute (CATTI) recently announced a collaborative strategy to streamline training standards and assessment in the advanced therapies manufacturing industry. The strategy sets the